"April 9, 2012 -- Drugs that treat incontinence caused by an overactive bladder offer modest benefits to some women, and they often come with significant side effects, a new review of research shows.
The government-funded review compar"...
OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
DOSAGE AND ADMINISTRATION
OXYTROL 3.9 mg/day should be applied to dry, intact skin on the abdomen, hip, or buttock twice weekly (every 3 or 4 days). A new application site should be selected with each new system to avoid re-application to the same site within 7 days.
Dosage Forms And Strengths
Transdermal System: 3.9 mg/day
Storage And Handling
Unit Dose: Heat sealed pouch containing 1 OXYTROL (oxybutynin transdermal system).
Each 39 cm² system imprinted with “OXYTROL 3.9 mg/day” contains 36 mg of oxybutynin for nominal delivery of 3.9 mg oxybutynin per day when dosed in a twice weekly regimen.
NDC 52544-920-08 Patient Calendar Box of 8 Systems
Store at 20-25°C (68-77°F). [See USP controlled room temperature.] Protect from moisture and humidity. Do not store outside the sealed pouch. Apply immediately after removal from the protective pouch. Discard used OXYTROL in household trash in a manner that prevents accidental application or ingestion by children, pets, or others.
Keep out of reach of children.
For all medical inquiries contact: WATSON Medical Communications Parsippany, NJ 07054 800-272-5525. Distributed By: Watson Pharma, Inc. Parsippany, NJ 07054 USA. Revised: 10/2012
Last reviewed on RxList: 10/18/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Oxytrol Information
Oxytrol - User Reviews
Oxytrol User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.